New chairman for Grifols

Victor Grifols Roura, who has devoted 50 years to building Spanish plasma-derived drugmaker Grifols (MCE: GRF) in senior roles including chief executive for 30 years, retires as non-executive chairperson. He is designated as chairperson of honor in recognition of his numerous contributions.

Steven Mayer, former co-head of Global Private Equity and chairman of the investment committee of private investment firm Cerberus Capital Management, with more than 10 years serving as a Grifols independent board member, is appointed as executive chairperson

These unanimously approved appointments are evidence of the board’s commitment to reinforce Grifols’ leadership; to accelerate the execution of the company’s strategic plan; to continue a focus on operational excellence; and to increase value for all shareholders, with emphasis on the reduction of debt levels and the improvement of the company’s cash flow profile.